Filtros de búsqueda

Lista de obras de Jeffrey S. Miller

"Self"-reflection by KIR

artículo científico publicado en 2009

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections

artículo científico publicado en 2003

A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation

artículo científico publicado en 2012

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

artículo científico publicado en 2007

A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia

artículo científico publicado en 2014

A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells

artículo científico publicado en 2020

ADAM17 and CD56low CD16low NK cells

artículo científico publicado en 2015

ARID5B regulates metabolic programming in human adaptive NK cells.

artículo científico publicado en 2018

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML.

artículo científico publicado en 2013

Activated notch supports development of cytokine producing NK cells which are hyporesponsive and fail to acquire NK cell effector functions.

artículo científico publicado en 2009

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Tr

artículo científico publicado en 2015

Adoptive Transfer of Umbilical Cord Blood-Derived Regulatory T Cells and Early Viral Reactivation ⬇️

artículo científico publicado el 25 de junio de 2013

Allogeneic natural killer cells for refractory lymphoma ⬇️

artículo científico publicado el 3 de agosto de 2010

Anti-HLA Antibodies in Double Umbilical Cord Blood Transplantation ⬇️

artículo científico publicado el 3 de mayo de 2011

BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs).

artículo científico publicado en 2003

Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion

artículo científico publicado en 2022

Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production

artículo científico publicado en 2012

Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes ⬇️

artículo científico publicado el 10 de noviembre de 2011

Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity

artículo científico publicado en 2013

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

artículo científico publicado en 2014

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation

artículo científico publicado en 2012

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression.

artículo científico publicado en 2014

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

artículo científico publicado en 2007

Clinical production and therapeutic applications of alloreactive natural killer cells.

artículo científico publicado en 2012

Clinical utility of natural killer cells in cancer therapy and transplantation

artículo científico

Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor

artículo científico publicado en 2002

Control of acute myeloid leukemia relapse--dance between KIRs and HLA

scientific article published on 01 August 2012

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

artículo científico publicado en 2006

Current strategies exploiting NK-cell therapy to treat haematologic malignancies

artículo científico publicado en 2018

Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

artículo científico publicado en 2011

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function

artículo científico publicado en 2015

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype

artículo científico publicado en 2010

Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults

artículo científico publicado en 2002

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus

artículo científico publicado en 2010

Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma

artículo científico publicado en 2007

Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation.

artículo científico publicado en 2005

Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists

artículo científico publicado en 2006

Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2004

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

artículo científico publicado en 2008

Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies

artículo científico publicado en 2010

Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma

artículo científico publicado en 2006

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer

artículo científico publicado en 2000

Epigenetic regulation of NK cell differentiation and effector functions ⬇️

artículo científico publicado el 28 de febrero de 2013

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors

article

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

scientific article published on 05 July 2002

Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy

artículo científico publicado en 2014

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function

artículo científico publicado en 2005

Factors predicting single-unit predominance after double umbilical cord blood transplantation ⬇️

artículo científico publicado el 26 de septiembre de 2011

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis

artículo científico publicado en 1999

Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma

artículo científico publicado en 2008

First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer.

artículo científico publicado en 2007

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

scientific article published on 01 July 2019

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial

artículo científico publicado en 2007

Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.

artículo científico publicado en 2014

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience

artículo científico publicado en 2007

Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products

artículo científico publicado en 2012

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.

artículo científico publicado en 2010

How killers kill

scientific article published on 01 July 2008

Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

artículo científico publicado en 2023

Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.

artículo científico publicado en 2012

Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs

artículo científico publicado en 2014

Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

artículo científico publicado en 2001

Human polymorphism and variable outcomes of cancer chemotherapy and transplantation.

artículo científico publicado en 2008

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

artículo científico publicado en 2003

Identification of a KIR antisense lncRNA expressed by progenitor cells.

artículo científico publicado en 2013

Immunotherapy with autologous tumour antigen-coated microbeads (large multivalent immunogen), IL-2 and GM-CSF in dogs with spontaneous B-cell lymphoma

artículo científico publicado en 2010

Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation ⬇️

artículo científico publicado el 18 de febrero de 2013

Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.

artículo científico publicado en 2011

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation

artículo científico publicado en 2009

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics ⬇️

artículo científico publicado el 15 de octubre de 2010

Innovative therapy for chronic myelogenous leukemia ⬇️

artículo científico publicado el 1 de febrero de 1998

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

artículo científico publicado en 2009

Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.

artículo científico publicado en 2013

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2010

Isolation and characterization of canine natural killer cells

artículo científico publicado en 2013

KIR B or not to be?...that is the question for ALL.

artículo científico publicado en 2014

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation

artículo científico publicado en 2005

Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.

artículo científico publicado en 2011

Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation

artículo científico publicado en 2009

Lineage relationships of human interleukin-22–producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells ⬇️

artículo científico publicado el 17 de enero de 2013

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma

artículo científico publicado en 2005

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma

artículo científico publicado en 2006

Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells

artículo científico publicado en 2008

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

artículo científico publicado en 2007

Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15

artículo científico publicado en 2008

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

artículo científico publicado en 2009

Myelodysplastic syndromes: the role of the immune system in pathogenesis

artículo científico publicado en 2011

NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic

scientific article published on 10 February 2010

NK Cells—From Bench to Clinic ⬇️

artículo científico publicado el 1 de enero de 2012

NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).

artículo científico publicado en 2013

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

artículo científico publicado en 2011

NK cells pave the road for alloengraftment

artículo científico publicado en 2016

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee

artículo científico publicado en 2011

Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods ⬇️

artículo científico publicado el 7 de diciembre de 2011

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

artículo científico publicado en 1999

Natural killer cells: a review of manufacturing and clinical utility.

artículo científico

Natural killer–cell differentiation by myeloid progenitors ⬇️

artículo científico publicado el 20 de diciembre de 2010

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

artículo científico publicado en 2012

Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation

artículo científico publicado en 2014

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

artículo científico publicado en 2019

Novel therapies for chronic myelogenous leukemia.

artículo científico publicado en 2001

Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression

artículo científico publicado en 2013

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation.

artículo científico publicado en 2013

Prolonged subcutaneous administration of 852A, a novel systemic toll‐like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies ⬇️

artículo científico publicado el 20 de junio de 2012

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma

artículo científico publicado en 2004

Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanoma.

artículo científico publicado en 2014

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

artículo científico publicado en 2003

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis

artículo científico publicado en 2007

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor

artículo científico publicado en 2008

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas

artículo científico publicado en 2010

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? ⬇️

artículo científico publicado el 31 de agosto de 2011

Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma

scientific article published on 01 June 2005

Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?

artículo científico publicado en 2009

Successful "in-flight" activation of natural killer cells during long-distance shipping

artículo científico publicado en 2012

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation ⬇️

artículo científico publicado el 10 de diciembre de 2011

Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs

artículo científico publicado en 2006

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

artículo científico publicado en 2011

Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition

artículo científico publicado en 2013

The Minnesota Molecular and Cellular Therapeutics Facility: a state-of-the-art biotherapeutics engineering laboratory.

artículo científico publicado en 2005

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples

scientific article published on 01 August 2019

The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

artículo científico publicado en 2014

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry

artículo científico publicado en 2006

The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells.

artículo científico publicado en 2014

The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells

artículo científico publicado en 2009

Therapeutic applications: natural killer cells in the clinic.

artículo científico publicado en 2013

Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.

artículo científico publicado en 2008

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9 ⬇️

artículo científico publicado el 8 de febrero de 2012

Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers

artículo científico publicado en 2010

Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.

artículo científico publicado en 2014

Transfusion-associated graft-versus-host disease: a perspective from a cell therapy laboratory

artículo científico publicado en 2009

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

artículo científico publicado en 2004

Use of allogeneic NK cells for cancer immunotherapy.

artículo científico publicado en 2011

Use of natural killer cells as immunotherapy for leukaemia.

artículo científico publicado en 2008

iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda